This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Drug Names(s): DPS-101
Description: DPS-101 is a novel synergistic combination therapy for topical treatment of plaque psoriasis. It comprises Calcipotriol (calcipotriene; a vitamin D3 analog) and Nicotinamide (a vitamin B3 derivative) in a specific ointment formulation.
Additional information available to subscribers only: